October 4, 2023
1 min read

Viatris Completes $1.2B Divestiture In India

Viatris has executed an agreement to divest its API business in India to Iquest Enterprises…reports Asian Lite News

Viatris (formerly known as Mylan Inc) has finalised two deals in India to divest its API (active pharmaceutical ingredients) and women’s healthcare businesses for a combined consideration of around $1.2 billion, the healthcare company said on Monday.

The United States-headquartered global healthcare company has centres in Pittsburgh, Shanghai, and Hyderabad.

Viatris has executed an agreement to divest its API business in India to Iquest Enterprises, a Hyderabad-based pharmaceutical company owned by Nimmagadda Prasad, the founder of Matrix Laboratories.

The transaction includes three manufacturing sites and a R&D lab in Hyderabad, three manufacturing sites in Vizag and third-party API sales. However, Viatris will retain some selective R&D capabilities in API.

The women’s healthcare business, which primarily relates to oral and injectable contraceptives, has been sold to Insud Pharma, a leading Spanish multinational pharmaceutical company. The deal includes two manufacturing facilities in India: one in Ahmedabad and the other in Sarigam.

Both the India deals are expected to close in Q1 2024, according to the Viatris statement. Jefferies and law firm Saraf & Partners were the advisors for the deal.

Viatris has also sold its OTC (over- the- counter) business in Europe and commercialisation rights in a few non-core markets as part of a global divestiture drive to pare debt.

“With this announcement the company has delivered its commitment to announce agreements on all planned divestitures by the end of 2023 within the company’s previously communicated range, after considering the estimated retained value,” the Viatris statement read.

“Including gross proceeds from the company’s completed biosimilars divestiture, the company expects to realize gross proceeds representing a multiple above 12x on 2022 estimated adjusted EBITDA for its portfolio of divested assets.

“The gross proceeds to the company from all divestitures under the terms of the agreements are up to $6.94 billion, or up to approximately $5.2 billion in estimated aggregate net proceeds, taking into consideration taxes and other costs, including related transaction costs,” the statement added.

ALSO READ: Aspire.io Acquires Commerceup

Previous Story

India Ranks 2nd In Phone Production

Next Story

Indian Shooting Stars Blaze A Trail At Asian Games

Latest from Business

‘India’s Digital Hub Ascends’

The event also featured discussions on the Quad Partnership for Cable Connectivity and Resilience, reiterating commitments made during the July 1 Quad Foreign Ministers’ Meeting India’s growing role as a key digital

India’s Job Market Surges

With hiring levels on the rise, compensation is expected to increase by 12-15% in metro cities and by 18-22% in emerging cities India’s festive season this year is poised to create more

India Inc Eyes Upswing

Private equity (PE) remained comparatively stable in Q2, clocking 357 deals worth $7.4 billion — the second-highest volume since Q4 2022. However, deal values dipped on a quarter-on-quarter basis due to the

Apple Appoints Sabih Khan as New COO

Khan will take over from Jeff Williams, who is stepping down from the role this month and will retire later this year…reports Asian Lite News Apple has announced that Sabih Khan, an
Go toTop

Don't Miss

‘Bengaluru breathes US-India relationship’  

Garcetti hailed the inauguration as a new beginning for the

1983: Kapil Recalls Historic Moments

’83’ highlights India winning the 1983 World Cup under the